FMR CORP 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-12 09:28 am Purchase |
2024-12-31 | 13G | Cogent Biosciences, Inc. COGT |
FMR CORP | 16,569,256 15.000% |
3,360,284![]() (+25.44%) |
Filing |
2024-11-07 09:24 am Purchase |
2024-11-06 | 13G | Cogent Biosciences, Inc. COGT |
FMR CORP | 13,208,972 12.068% |
4,889,561![]() (+58.77%) |
Filing |
2024-11-07 09:12 am Purchase |
2024-11-06 | 13G | Cogent Biosciences, Inc. COGT |
FMR CORP | 8,319,411 7.601% |
3,016,557![]() (+56.89%) |
Filing |
2024-02-09 08:50 am Purchase |
2024-02-08 | 13G | Cogent Biosciences, Inc. COGT |
FMR CORP | 5,302,854 6.157% |
5,302,854![]() (New Position) |
Filing |